U.S. Markets open in 7 hrs 14 mins

Zacks Investment Ideas feature highlights: Apple

Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.

For Immediate Release

Chicago, IL – September 12, 2018 – Today, Zacks Investment Ideas feature highlights Features: Apple AAPL.

What to Look for in Apple’s (AAPL) Product Release

On Wednesday, Apple will hold a long-awaited media event at its Cupertino, CA headquarters to unveil the next generation of iPhones and other Apple products. These product releases have been a cornerstone of Apple’s marketing and investor relations strategies since the days of Steve Jobs and the public’s first ever look at an iPhone in 2007.

These media events also provide valuable insight into future because the new products introduced are often not available for sale until months after the official introduction and thus do not affect revenues and earnings in the current quarter, but anticipation of their likely demand will help shape estimates for the following year.

This is a particularly important event for Apple as they are expected to introduce an entre new line of iPhones - and iPhones currently make up more than 56% of Apple’s revenues. The release last year of the iPhone X was met with mixed reviews with its innovative features like an OLED screen and facial recognition, but also its equally innovative price of $999 – the most expensive phone ever.

The iPhone X has in fact sold very well even at $999, but current predictions are for a new line that incudes less expensive phones that will incorporate some of the unique features of the X, but at more affordable prices as well as an update of the flagship model with a larger screen.

Both Apple and Samsung have moved toward more expensive phones with enhanced features, recognizing that many customers are upgrading at a slower pace than they used to.

It’s worth noting that the official press invitation Apple sent out for Wednesday’s event did not specify that a new iPhone will be released, but September has traditionally been when phones have been announced and the illustration on the invitation appears to be a rendering of the profile of two new phones of varying sizes.

The “tech geek” press has been salivating over the rumors and possibilities since the invitations went out at the end of August.

Apple is also expected to introduce a 4th generation Watch with an edge to edge display, a larger screen and possibly even an EKG feature added to the heart-rate monitor. The Watch has been a steady if unspectacular product for Apple since its introduction in 2015, contributing less than 7% or revenues in the most recent quarter but acquiring a loyal group of tech-savvy devotees.

Finally, an updated iPad is expected that loses the “home” button on the front side, making way for a bigger screen without increasing the overall size of the device.

What Should Investors Look For?

Everyone loves new and improved gadgets and Apple has become the biggest company in the world by consistently delivering the best and newest, while retaining brand cache that allows them to sell new products at strong margins. The most important aspect of Wednesday’s presentation however will not necessarily be the products themselves, but rather analyst reactions in the form of revised revenue and earnings projections.

Thanks to 10 positive revisions over the past 60 days, Apple is currently a Zacks Ranks #1 (Strong Buy). In fiscal year 2019 – which begins after the current quarter – Apple is expected to earn $13.26/share on $272B in revenues.

If the investing community expects that the new products will drive increased sales, we’ll see those numbers increase even further in the days and weeks after the presentation. Even if the revenue figure stays relatively the same but the consensus earnings estimate increases, it will provide validation of Apple’s strategy to sell new products at higher retail prices and improving margins – a very healthy indicator for the company.

There’s bound to be some stock movement around the announcement on Wednesday, but this will be largely noise – just day traders fighting over a few pennies. Serious investors will keep an eye on the estimates after the event.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions. New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>

Follow us on Twitter:  https://twitter.com/ZacksResearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Apple Inc. (AAPL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.